• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 28, 2017

View Archived Issues

Roche details development of the first V1aR antagonist for social communication deficits in autism

Read More

MeiraGTx updates progress of AAV-mediated ocular gene therapy programs

Read More

Novel soluble S1P carrier shows efficacy in preclinical models of hypertension and ischemic injury

Read More

Long-term cMD1 gene therapy shows efficacy in a canine model of Duchenne muscular dystrophy

Read More

FDA approves Kedrab for post-exposure prophylaxis of rabies infection

Read More

Actemra approved in Japan for additional indications of Takayasu arteritis and giant cell arteritis

Read More

Mavenclad granted European approval for the treatment of highly active relapsing MS

Read More

Vimpat approved in Japan as monotherapy for partial onset seizures in patients with epilepsy

Read More

Initial clinical experience reported for AZD-5718 in healthy subjects

Read More

Treatment begins in phase I/II trial of SB-525 in severe hemophilia A

Read More

Yangtze River Pharmaceutical Group and collaborator patent Nav1.7 channel blockers

Read More

Fochon Pharma and collaborators present ALK inhibitors

Read More

Shenzhen Targetrx Biotechnology divulges novel CYP17A1 inhibitors

Read More

AstraZeneca initiates phase I study of AZD-5991 in relapsed or refractory hematologic malignancies

Read More

AstraZeneca AB and Eolas Therapeutics patent orexin receptor antagonists

Read More

FDA grants breakthrough therapy designation to mogamulizumab for CTCL subtypes

Read More

Roche discloses new DDR1 inhibitors

Read More

Takeda describes discovery of GPR139 agonist TAK-041 for treating negative schizophrenia symptoms

Read More

NantKwest initiates phase I study of haNK in advanced solid tumors

Read More

FDA grants priority review to Gazyva sBLA for untreated follicular lymphoma

Read More

Janssen reports findings from COMPASS trial of Xarelto in coronary and peripheral artery disease

Read More

Philogen subsidiary collaborates with Servier on small molecule discovery

Read More

Sanofi completes acquisition of Protein Sciences

Read More

Six-month results reported from phase IIb study of GNbAC-1 for relapsing-remitting MS

Read More

FDA approves Victoza to reduce risk of major adverse CV events in patients with type 2 diabetes

Read More

Xoma licenses gevokizumab commercial rights to Novartis

Read More

EMA validates for review MAAs for combination of binimetinib and encorafenib

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe